Cocoon Platform by Lonza Group Ltd

Manufacturer Lonza Group Ltd  |  Available Worldwide
5.0
/
5.0
  |  1 reviews
The Cocoon ® Platform streamlines patient-scale cell therapy manufacturing for greater efficiency and reliability. Automated, closed, and flexible, this end-to-end cell manufacturing platform gives you increased control over your specific process.


Cocoon Platform by Lonza Group Ltd product image
Cocoon Platform

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2019

  • Organization: Lonza



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Very good expansion folds and cost efficiencies. Patients treated successfully.
Rating: 5.0

  • Application Area: Automated cell culture platform for autologous therapies

"Very easy to use platfom. Helps reduce labor and reagent costs. Fully flexible and customizable. Excellent support for the process development, process initiation and process maintenance."

Review date: 06 Dec 2021 | Cocoon Platform

The Cocoon® Platform streamlines patient-scale cell therapy manufacturing for greater efficiency and reliability. Automated, closed, and flexible, this end-to-end cell manufacturing platform gives you increased control over your specific process.

Highly customizable and scalable, the Cocoon® Platform is an integrated turnkey solution ready to use off-the-shelf. If you want full customization, we’ll work with you to tailor it to your unique process. Designed to save time and lower costs, Cocoon® enables you to quickly and efficiently advance your project from pre-clinical through commercial-scale manufacturing. Whether manufacturing in a centralized or decentralized model, our approach to cell therapy manufacturing with the Cocoon® Platform reduces costs and risk, while improving overall product quality.